Real-world long-term effectiveness of ustekinumab in ulcerative colitis: results from a spanish open-label cohort.

MLA

Iborra, Marisa, et al. “Real-World Long-Term Effectiveness of Ustekinumab in Ulcerative Colitis: Results from a Spanish Open-Label Cohort.” Scandinavian Journal of Gastroenterology, vol. 59, no. 3, Mar. 2024, pp. 260–68. EBSCOhost, https://doi.org/10.1080/00365521.2023.2278427.

APA

Iborra, M., Ferreiro-Iglesias, R., Maria Dolores, M.-A., Mesonero Gismero, F., Mínguez, A., Porto-Silva, S., García-Ramírez, L., García de la Filia, I., Aguas, M., Nieto-García, L., Suárez Ferrer, C., Bastida, G., Barreiro-De-Acosta, M., & Nos, P. (2024). Real-world long-term effectiveness of ustekinumab in ulcerative colitis: results from a spanish open-label cohort. Scandinavian Journal of Gastroenterology, 59(3), 260–268. https://doi.org/10.1080/00365521.2023.2278427

Chicago

Iborra, Marisa, Rocio Ferreiro-Iglesias, Martín-Arranz Maria Dolores, Francisco Mesonero Gismero, Alejandro Mínguez, Sol Porto-Silva, Laura García-Ramírez, et al. 2024. “Real-World Long-Term Effectiveness of Ustekinumab in Ulcerative Colitis: Results from a Spanish Open-Label Cohort.” Scandinavian Journal of Gastroenterology 59 (3): 260–68. doi:10.1080/00365521.2023.2278427.